ReviewCurrent urology reports2018
Management of Overactive Bladder in Older Women.
Review in Current urology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Vaginal Estradiol vs Oral Beta-3 Agonist for Treatment of Overactive Bladder Syndrome: A Single-Therapy, Double-Blind, Randomized Controlled Trial
Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women: A Randomized Double-Blind, Placebo-Controlled Study
Who cites it
19 citing papers in PubMed.
- Health-related quality of life among Chinese primary care patients with different lower urinary tract symptoms: a latent class analysis.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021Trial
- Transcutaneous tibial nerve stimulation versus parasacral stimulation in the treatment of overactive bladder in elderly people: a triple-blinded randomized controlled trial.Clinics (Sao Paulo, Brazil) · 2020Trial
- Associations of Vaginal Pressure and Transversus Abdominis Muscle Thickness with Overactive Bladder in Women: A Cross-Sectional Study.Medicina (Kaunas, Lithuania) · 2026Article
- Clinical predictors of symptom and quality-of-life improvement with antimuscarinics in overactive bladder: a 12-month prospective cohort study in Türkiye.BMC urology · 2026Observational
- The use of intradetrusor botulinum toxin in the geriatric population.BJUI compass · 2025Article
- Exploring the Association Between Overactive Bladder (OAB) and Cognitive decline: mediation by depression in elderly adults, a NHANES weighted analysis.Scientific reports · 2025Article
- Device-Related Reoperations 8 Years Following Sacral Neuromodulation Implantation in Older Women.International urogynecology journal · 2024Article
- An Investigational Study on the Role ofPharmaceuticals (Basel, Switzerland) · 2024Article
- Long term follow-up after minimally invasive sacrocolpopexy.International urogynecology journal · 2023Article
- Pre- versus Post-Menopausal Onset of Overactive Bladder and the Response to Vaginal Estrogen Therapy: A Prospective Study.Medicina (Kaunas, Lithuania) · 2023Article
- Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder.Canadian geriatrics journal : CGJ · 2022Review
- The Efficacy and Safety of Transurethral 2 μm Laser Bladder Lesion Mucosal En Bloc Resection in the Treatment of Cystitis Glandularis.Frontiers in medicine · 2022Article
- Efficacy of non-pharmacological interventions in patients with overactive bladder: A protocol for systematic review and network meta-analysis.Nursing open · 2022Article
- Does age alone negatively predict the outcome of sacral neuromodulation? A single-centre retrospective observational study.BMC urology · 2020Observational
- Recent advances in managing overactive bladder.F1000Research · 2020Review
- Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder.Clinical interventions in aging · 2020Review
- Advances in pharmacotherapy for the treatment of overactive bladder.Current bladder dysfunction reports · 2019Article
- Dilemmas in Management of the Geriatric Bladder.Current bladder dysfunction reports · 2019Article
- Role of β-3 adrenergic receptor polymorphism in overactive bladder.Neurourology and urodynamics · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
purpose of reviewThis review will highlight our current understanding of age-related changes in bladder function and propose important clinical considerations in the management of overactive bladder (OAB) specific to older women. RECENT
findingsFrailty, functional and cognitive impairment, multimorbidity, polypharmacy, estrogen deficiency, and remaining life expectancy are important clinical factors to consider and may impact OAB symptom management in older women. Third-line therapies, particularly PTNS, may be preferable over second-line therapy in some cases. Due to the complexity within this population, the standard treatment algorithms may not be applicable, thus a broader, more holistic focus is recommended when managing OAB in older women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.